Abstract Background and Aims The delicate balance of risk versus benefit oral anticoagulation in the general population is well established but decision to use these agents end-stage renal disease (ESRD) remains complex difficult owing paucity clinical trials lack substantial evidence literature for its safe effective haemodialysis population. This study aims determine difference outcomes betwe...